Literature DB >> 26253325

Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Hussam Abou Al-Shaar1, Kaith K Almefty2,3, Mohammad Abolfotoh2, Nils D Arvold4, Phillip M Devlin4, David A Reardon5, Jay S Loeffler6, Ossama Al-Mefty7.   

Abstract

Recurrent aggressive falcine meningiomas are uncommon tumors that recur despite receiving extensive surgery and radiation therapy (RT). We have utilized brachytherapy as a salvage treatment in two such patients with a unique implantation technique. Both patients had recurrence of WHO Grade II falcine meningiomas despite multiple prior surgical and RT treatments. Radioactive I-125 seeds were made into strands and sutured into a mesh implant, with 1 cm spacing, in a size appropriate to cover the cavity and region of susceptible falcine dura. Following resection the vicryl mesh was implanted and fixed to the margins of the falx. Implantation in this interhemispheric space provides good dose conformality with targeting of at-risk tissue and minimal radiation exposure to normal neural tissues. The patients are recurrence free 31 and 10 months after brachytherapy treatment. Brachytherapy was an effective salvage treatment for the recurrent aggressive falcine meningiomas in our two patients.

Entities:  

Keywords:  Atypical meningioma; Brachytherapy; Falcine; Falcine meningioma; I-125; Meningioma

Mesh:

Year:  2015        PMID: 26253325     DOI: 10.1007/s11060-015-1873-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

Review 1.  Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas.

Authors:  J B Halligan; K J Stelzer; R C Rostomily; A M Spence; T W Griffin; M S Berger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-06-01       Impact factor: 7.038

2.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

3.  Radiation exposure to medical personnel during iodine-125 seed implantation of the prostate.

Authors:  J Liu; F M Edwards
Journal:  Radiology       Date:  1979-09       Impact factor: 11.105

Review 4.  Brachytherapy for brain tumor.

Authors:  J H Suh; G H Barnett
Journal:  Hematol Oncol Clin North Am       Date:  1999-06       Impact factor: 3.722

Review 5.  Re-treatment after full-course radiotherapy: is it a viable option?

Authors:  F A Stewart
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

6.  Role of brachytherapy in the management of the skull base meningioma. Treatment of skull base meningiomas.

Authors:  P P Kumar; A A Patil; H W Syh; W K Chu; M A Reeves
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

Review 7.  High activity iodine 125 endocurietherapy for recurrent skull base tumors.

Authors:  P P Kumar; R R Good; L G Leibrock; J R Mawk; A J Yonkers; F P Ogren
Journal:  Cancer       Date:  1988-04-15       Impact factor: 6.860

8.  Radiosurgery for parasagittal and parafalcine meningiomas.

Authors:  Dale Ding; Zhiyuan Xu; Ian T McNeill; Chun-Po Yen; Jason P Sheehan
Journal:  J Neurosurg       Date:  2013-08-09       Impact factor: 5.115

9.  Effect of tumour shrinkage on the biological effectiveness of permanent brachytherapy implants.

Authors:  R G Dale; B Jones; I P Coles
Journal:  Br J Radiol       Date:  1994-07       Impact factor: 3.039

Review 10.  Radiation Treatment for WHO Grade II and III Meningiomas.

Authors:  Brian P Walcott; Brian V Nahed; Priscilla K Brastianos; Jay S Loeffler
Journal:  Front Oncol       Date:  2013-09-02       Impact factor: 6.244

View more
  4 in total

1.  Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.

Authors:  Matthew J Koch; Pankaj K Agarwalla; Trevor J Royce; Helen A Shih; Kevin Oh; Andrezj Niemierko; Thomas C Mauceri; William T Curry; Frederick G Barker; Jay S Loeffler
Journal:  Neurosurgery       Date:  2019-11-01       Impact factor: 4.654

2.  Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis.

Authors:  Kyle C Wu; Jonathan M Cantalino; Edward C Dee; Liangge Hsu; Thomas C Harris; Bhupendra Rawal; Parikshit R Juvekar; Michael A Mooney; Ian F Dunn; Ayal A Aizer; Phillip M Devlin; Wenya Linda Bi
Journal:  Neurooncol Adv       Date:  2022-04-22

3.  Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.

Authors:  Michael A Mooney; Wenya Linda Bi; Jonathan M Cantalino; Kyle C Wu; Thomas C Harris; Lucas L Possatti; Parikshit Juvekar; Liangge Hsu; Ian F Dunn; Ossama Al-Mefty; Phillip M Devlin
Journal:  J Neurooncol       Date:  2019-11-19       Impact factor: 4.130

4.  The Undetermined Destiny of Case Reports in the Era of Sophisticated Medicine.

Authors:  Hussam Abou-Al-Shaar; Abdulrahman J Sabbagh
Journal:  World Neurosurg       Date:  2017-05       Impact factor: 2.104

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.